An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

NCT00127647 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1375

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG: montelukast sodium
DRUG: Comparator: pranlukast

Sponsor

Organon and Co